U.S., April 23 -- ClinicalTrials.gov registry received information related to the study (NCT06938165) titled 'The Safety and Efficacy of Fecal Microbiota Transplant (FMT) for Steroid-refractory Graft-versus-host Disease' on April 10.

Brief Summary: This clinical study evaluates the safety and efficacy of fecal microbiota transplantation (FMT) in patients with steroid-refractory graft-versus-host disease (GVHD).

Study Start Date: April 27, 2020

Study Type: INTERVENTIONAL

Condition: GVHD

Intervention: OTHER: Fecal Microbiota Transplant (FMT)

FMT in patients with refractory GVHD

Recruitment Status: COMPLETED

Sponsor: Nanfang Hospital, Southern Medical University

Published by HT Digital Content Services with permission from Health Da...